The inauguration ceremony of the "Guangdong-Hong Kong-Macao Greater Bay Area Life Health Industry Innovation Zone CRO Industry Landmark Yuexiu District Operational Center" took place on February 10, 2023, at Zhushi Tongchuang·Huandong Plaza in Yuexiu District, Guangzhou. Distinguished attendees included:
- Chen Xi, Deputy District Mayor of Yuexiu District
- Li Song, Deputy Director of Yuexiu District Science, Technology and Industry Bureau
- Lin Xiaoyan, Director of Policy Regulations and Innovation System Construction Department at Guangzhou Municipal Science and Technology Bureau
Key Attendees and Industry Support
The event gathered prominent industry leaders:
- Zheng Zhihua: Vice Chairman and Secretary-General of Guangdong Pharmaceutical Association
- Yan Qunchao: President of Guangdong Anti-Aging Research Association
- Wu Yuxiong: Chairman of Guangdong Family Doctor Association
- Wu Chusheng: Chairman of Guangdong Medical Device Association
- Sun Binggang: Secretary-General of Guangdong Precision Medicine Application Association
- Wang Shuaishuai: General Manager of Guangzhou Hipower Pharmaceutical Technology Co., Ltd. (representing CRO sector)
Deputy Mayor Chen Xi emphasized Yuexiu District's natural advantages for biopharmaceutical development and highlighted CRO's critical role in strengthening the biopharmaceutical industry chain. The district specially recognized Zhushi Tongchuang·Huandong Plaza with the operational center designation.
Pioneering Proposal and Government Response
The landmark initiative traces back to a groundbreaking proposal:
- Submitted by Wang Shuaishuai (District CPPCC member and CRO expert)
- Simultaneously approved by Guangdong Province, Guangzhou City, and Huangpu District CPPCC sessions
- Awarded 2023 Guangzhou CPPCC Outstanding Proposal
Yuexiu District responded swiftly by establishing China's first CRO industry landmark operational center, with neighboring districts like Huangpu and Haizhu preparing to join this Greater Bay Area initiative.
CRO's Strategic Role in Pharmaceutical Innovation
Wang Shuaishuai explained CRO's pivotal functions:
"As platform companies, CROs bridge all critical elements in the pharmaceutical ecosystem - government, industry, academia, research, investment, medical institutions, and financing. They serve as vanguards for the biopharmaceutical sector's high-growth potential."
Hipower Pharmaceutical Technology commits to:
- Enhancing Guangzhou's biopharmaceutical industry vitality
- Creating CRO cluster effects
- Developing comprehensive technical service capabilities
- Accelerating research成果转化 (achievement transformation)
Operational Center's Strategic Objectives
The center will leverage Yuexiu District's unmatched resources:
- Medical Resources: Highest concentration of top-tier hospitals in South China
- Industry Assets: Abundant pharmaceutical enterprises and specialized talent
Key development strategies include:
- CRO cluster formation
- Biopharmaceutical resource integration
- Upstream/downstream enterprise recruitment
- Medical institution成果转化 ecosystem development
👉 Discover how CRO innovations are transforming healthcare
Frequently Asked Questions
What makes this CRO operational center unique?
This represents China's first government-recognized CRO industry landmark, combining regional medical resources with policy support to create an integrated biopharmaceutical innovation hub.
How will the center benefit pharmaceutical companies?
By providing comprehensive CRO services and facilitating connections across the research-to-commercialization pipeline, it significantly reduces development timelines and costs for drug companies.
What's the significance of choosing Yuexiu District?
The district's unparalleled concentration of medical institutions (over 20 tertiary hospitals) and existing pharmaceutical infrastructure make it the ideal location for accelerating clinical research and成果转化.
👉 Explore cutting-edge pharmaceutical development strategies
This landmark initiative positions Guangzhou at the forefront of China's biopharmaceutical innovation, creating a replicable model for high-quality industry development nationwide.